KFDA to specify scope of stability test data for new and generic drugs.

The KFDA Drug Safety Bureau and Drug Review Department announced a unified standard to define the scope of stability test data required for a new and generic drug registration through "Pharmaceutical Regulatory Standards Study Council"

The new standards clearly defined the required stability test data by each case of the new and generic drugs, and that a new drug be granted with 24 month of ...